Found: 14
Select item for more details and to access through your institution.
High Prevalence of Chronic Gastrointestinal Symptoms in a National Guard Unit of Persian Gulf Veterans.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 1996, v. 91, n. 12, p. 2494
- By:
- Publication type:
- Article
Population Exposure-Response Modeling of Naloxegol in Patients With Noncancer-Related Pain and Opioid-Induced Constipation.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2016, v. 5, n. 7, p. 359, doi. 10.1002/psp4.12099
- By:
- Publication type:
- Article
Simulation and Prediction of the Drug-Drug Interaction Potential of Naloxegol by Physiologically Based Pharmacokinetic Modeling.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2016, v. 5, n. 5, p. 250, doi. 10.1002/psp4.12070
- By:
- Publication type:
- Article
Relationship between intragastric acid control and healing status in the treatment of moderate to severe erosive oesophagitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2007, v. 25, n. 5, p. 617, doi. 10.1111/j.1365-2036.2006.03235.x
- By:
- Publication type:
- Article
Healing rates for moderate and severe oesophagitis.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Comparison of the effects of intravenously and orally administered esomeprazole on acid output in patients with symptoms of gastro-oesophageal reflux disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2005, v. 22, n. 9, p. 813, doi. 10.1111/j.1365-2036.2005.02659.x
- By:
- Publication type:
- Article
Efficacy of esomeprazole 40 mg vs. lansoprazole 30 mg for healing moderate to severe erosive oesophagitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2005, v. 21, n. 4, p. 455, doi. 10.1111/j.1365-2036.2005.02339.x
- By:
- Publication type:
- Article
Intragastric acid suppression and pharmacokinetics of twice-daily esomeprazole: a randomized, three-way crossover study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2004, v. 20, n. 4, p. 399, doi. 10.1111/j.1365-2036.2004.02079.x
- By:
- Publication type:
- Article
Esomeprazole administered through a nasogastric tube provides bioavailability similar to oral dosing.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2003, v. 18, n. 6, p. 581, doi. 10.1046/j.1365-2036.2003.01667.x
- By:
- Publication type:
- Article
Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2014, v. 40, n. 7, p. 771, doi. 10.1111/apt.12899
- By:
- Publication type:
- Article
Clinical trial: evaluation of gastric acid suppression with three doses of immediate-release esomeprazole in the fixed-dose combination of PN 400 (naproxen/esomeprazole magnesium) compared with naproxen 500 mg and enteric-coated esomeprazole 20 mg: a randomized, open-label, Phase I study in healthy volunteers
- Published in:
- Alimentary Pharmacology & Therapeutics, 2010, v. 32, n. 3, p. 414, doi. 10.1111/j.1365-2036.2010.04361.x
- By:
- Publication type:
- Article
Clinical trial: the incidence of NSAID-associated endoscopic gastric ulcers in patients treated with PN 400 (naproxen plus esomeprazole magnesium) vs. enteric-coated naproxen alone.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2010, v. 32, n. 3, p. 401, doi. 10.1111/j.1365-2036.2010.04378.x
- By:
- Publication type:
- Article
Intravenous esomeprazole 40 mg vs. intravenous lansoprazole 30 mg for controlling intragastric acidity in healthy adults.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2008, v. 27, n. 6, p. 483, doi. 10.1111/j.1365-2036.2007.03592.x
- By:
- Publication type:
- Article
EVIDENCE FOR THE UNCONDITIONABILITY OF THE BABKIN REFLEX IN NEWBORNS.
- Published in:
- Child Development, 1972, v. 43, n. 2, p. 509, doi. 10.2307/1127552
- By:
- Publication type:
- Article